Amicus Therapeutics (FOLD) Announces Proposed Common Stock Offering
Tweet
Share
E-mailGet Alerts FOLD Hot Sheet
Join SI Premium – FREE
Amicus Therapeutics (Nasdaq: FOLD) has commenced an underwritten public offering of its common stock. Leerink Swann LLC and Cowen and Company, LLC are acting as joint book-running managers. The Company expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of common stock offered in the public offering to cover over-allotments, if any.
The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the final size or terms of the offering.
The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the final size or terms of the offering.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FocalTherics prices public offering of 8.4 million ADS at $4.75 each
- TD Cowen Upgrades Sezzle Inc (SEZL) to Buy 'on more compelling valuation'
- Silexion Therapeutics prices $2.5M public offering at $0.65 per share
Create E-mail Alert Related Categories
Equity OfferingsRelated Entities
Cowen & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
